Full List Of Stories
Week ahead: A blizzard of results and macro news
A deep freeze is forecast in the UK next week and as February segues into March there will be a blizzard of company results, a flurry of key macro data for China, Europe and the US, and hope that frosty relations can thaw in a new round of Brexit talks.
Market buzz: Stocks jump off lows ... led by defensives
1731: Interest rate sensitive stocks paced gains on the top flight index on Friday, with BT Group, United Utilities, Severn Trent, British America Tobacco and British Land at the top of the leaderboard. In the background, yields on longer-term Gilts were lower, tracking a fall in those for similarly-dated Treasuries on other side of the Atlantic. Triggering those moves was what some observers described as a less hawkish than expected monetary policy report to Congress from the Federal Reserve.
Astra and MSD get positive cancer news from EU agency
AstraZeneca and US partner Merck & Co (MSD) have received a positive opinion from European drug regulators over their ovarian, fallopian tube, or peritoneal cancer therapy.
RBS reports first profit in a decade but higher costs loom
Royal Bank of Scotland clambered back into the black in 2017 for the first time in a decade, though though the taxpayer-owned bank took a late hit from legacy charges and warned of higher restructuring charges in 2018.
Aviva boosts capital surplus as it says adios to Spain
Life insurer Aviva has almost entirely pulled out of Spain after selling out of two more life and pensions joint ventures in the country for £178m in cash.